Ursolic Acid and Its Therapeutic Applications in Cancer Biology

Ursolic acid is a naturally occurring pentacyclic triterpenoid widely distributed in many fruits, herbs and medicinal plants. Its planar five‐ring scaffold and carboxyl and hydroxyl functional groups confer diverse biological activities, most notably anticancer effects. In cellular models, ursolic acid inhibits tumour initiation and progression by inducing programmed cell death (apoptosis), stimulating autophagy and arresting cell cycle progression. It modulates multiple signalling pathways, including those governed by NF-κB, STAT3 and mitogen-activated kinases, thereby suppressing proliferation, invasion and metastasis. Preclinical studies have demonstrated chemopreventive benefits in models of prostate, breast and colon cancer, often via downregulation of pro-inflammatory mediators and upregulation of caspases. Despite robust in vitro efficacy, clinical translation has been hindered by poor water solubility and limited oral bioavailability. To address these challenges, researchers have pursued chemical derivatisation to enhance pharmacokinetic properties and employed advanced delivery systems—such as nanofibres, liposomes and polymeric nanoparticles—to improve tissue targeting and reduce systemic toxicity. Together, these efforts underscore the promise of ursolic acid as an adjunct or alternative to current therapeutic regimens, offering a low-cost natural compound with multitarget anticancer potential.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Ursolic Acid and Its Therapeutic Applications in Cancer Biology publication trend

The graph below shows the total number of articles in ursolic acid and its therapeutic applications in cancer biology across all publications each year (not limited to Nature Index journals).

Technical terms

Pentacyclic triterpenoid: A class of natural compounds featuring a five‐ring structure derived from plant metabolism.

Apoptosis: Programmed cell death characterised by chromatin condensation, membrane blebbing and caspase activation.

Autophagy: A cellular degradation process in which organelles and proteins are sequestered and recycled via lysosomal pathways.

Bioavailability: The proportion of a compound that reaches systemic circulation in an active form.

Derivatization: Chemical modification of a molecule to alter its physical or biological properties.

Nanofibre: A nano-scale fibrous material often used as a drug delivery scaffold to improve solubility and tissue penetration.

Caspase-3: An executioner enzyme that mediates the cleavage of cellular substrates during apoptosis.

References

1. An Update on Pentacyclic Triterpenoids Ursolic and Oleanolic Acids and Related Derivatives as Anticancer Candidates. Antioxidants (2024).
2. Improving Water Solubility and Skin Penetration of Ursolic Acid through a Nanofiber Process to Achieve Better In Vitro Anti-Breast Cancer Activity. Pharmaceutics (2024).
3. Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update. International Journal of Molecular Sciences (2020).